There has been remarkable growth in Singapore's pharmaceutical/medical industries, one of the sectors being promoted on a priority basis by the country, and many of the world's leading pharmaceutical companies have set up research, development and manufacturing locations there in what is fast becoming an industrial cluster. Accordingly, pharmaceutical import/export demand utilizing Changi Airport, which is increasingly distinguishing itself as a user-friendly free trade port, is expected to rise in future. With this GDP certification, NE Singapore will have in place a system to provide safe and high-quality air import/export services for pharmaceuticals that leverage the benefits of being the only Japanese logistics company with a facility within the airport's bonded area.